APA (7th ed.) Citation

Liu, M., Su, Y., Hu, Y., Shen, M., Bao, S., Gong, Y., . . . Zhou, L. (2026). The secretory protein, CLCF1, improves cholestatic liver disease by inhibiting hepatic bile acid synthesis and promoting bile acid excretion. Communications Biology, 9(1), 1. https://doi.org/10.1038/s42003-026-09847-w

Chicago Style (17th ed.) Citation

Liu, Man, et al. "The Secretory Protein, CLCF1, Improves Cholestatic Liver Disease by Inhibiting Hepatic Bile Acid Synthesis and Promoting Bile Acid Excretion." Communications Biology 9, no. 1 (2026): 1. https://doi.org/10.1038/s42003-026-09847-w.

MLA (9th ed.) Citation

Liu, Man, et al. "The Secretory Protein, CLCF1, Improves Cholestatic Liver Disease by Inhibiting Hepatic Bile Acid Synthesis and Promoting Bile Acid Excretion." Communications Biology, vol. 9, no. 1, 2026, p. 1, https://doi.org/10.1038/s42003-026-09847-w.